The prognostic value of the tumor–stroma ratio is most discriminative in patients with grade III or triple‐negative breast cancerKiki M. H. Vangangelt, Wilma E. Mesker, Gabi W. van Pelt et al.|International Journal of Cancer|2020Cited by 72
The prognostic value of the tumour-stroma ratio in primary operable invasive cancer of the breast: a validation studyToni Roeke, Wilma E. Mesker, Marcelo Sobral‐Leite et al.|Breast Cancer Research and Treatment|2017Cited by 67